ACCD

Accolade Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

ACCD price

Accolade

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ACCD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ACCD

Valuation

P/E

Sector 1.14

Industry 3.38

P/BV

Sector 1.86

Industry 2.20

P/Revenue (PSR)

Sector 1.56

Industry 1.80

EV/EBITDA

1.02

Sector -48.05

Industry 2.35

EV/EBIT

0.62

Sector -27.46

Industry -3.67

P/EBITDA

Sector -32.50

Industry -53.91

P/EBIT

Sector -43.68

Industry -50.80

P/Total Assets

Sector 0.88

Industry 1.01

P/Net Current Assets

0.00

Sector -27.11

Industry -10.74

P/Working Capital

0.00

Sector 2.78

Industry 2.87

EPS

Sector -0.70

Industry -0.60

BVPS

Sector 4.34

Industry 5.06

Efficiency

Gross Margin

Sector 49.36%

Industry 50.85%

EBITDA Margin

-15.05%

Sector -283.40%

Industry -56.64%

EBIT Margin

-24.61%

Sector -164.84%

Industry -55.50%

Operating Margin

Sector -19.73%

Industry -25.35%

Net Profit Margins

Sector -24.22%

Industry -28.78%

Asset Turnover

0.16

Sector 0.13

Industry 0.15

Profitability

ROE

Sector -24.32%

Industry -22.56%

ROA

Sector -24.41%

Industry -24.19%

ROIC

-20.53%

Sector -529.97%

Industry -94.15%

Dividends

Dividend yield

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.63

Sector 1.90

Industry 2.01

Net Debt / EBITDA

1.02

Sector -4.96

Industry -2.23

Net Debt / EBIT

0.62

Sector -3.08

Industry -1.54

Net Debt / Equity

-0.05

Sector -0.45

Industry -0.28

Gross Debt / Equity

0.67

Sector -0.74

Industry -0.81

Equity/Assets

0.48

Sector 0.46

Industry 0.47

Liabilities/Assets

Sector 0.49

Industry 0.52

Growth

5Y Revenue CAGR

7.33%

Sector -

Industry -

5Y Earnings CAGR

34.80%

Sector -

Industry -

Fundamentals ACCD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ACCD Accolade Inc.	$0.00	-	0.00%	0.00	0.00	0.00%	0.00%
HCA HCA Healthcare Inc.	$432.15	6.24%	0.70%	12.06	-29.52	-244.72%	10.07%
FMS Fresenius Medical Care AG & Co.	$22.39	-10.40%	2.77%	10.85	0.76	7.01%	4.84%
HUM Humana Inc.	$377.85	48.71%	0.93%	35.53	2.39	6.72%	0.89%
DVA DaVita Inc.	$177.43	33.58%	0.00%	9.90	-24.44	-246.80%	8.49%
WTW Weight Watchers International, Inc	$295.62	-11.91%	1.22%	18.44	3.74	20.26%	15.58%
LH Laboratory Corporation of America Holdings	$304.41	9.85%	0.90%	26.19	3.05	11.64%	6.99%
ALHC Alignment Healthcare Inc.	$7.48	-56.10%	0.00%	43.76	6.72	15.35%	0.89%
SGRY Surgery Partners Inc.	$14.22	-34.68%	0.00%	20.73	0.55	2.64%	2.43%
LLY Eli Lilly and Compay	$1,194.60	60.94%	0.59%	38.16	30.09	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$403.68	-9.84%	0.00%	44.01	7.60	17.26%	28.62%
SNY Sanofi	$41.25	-8.54%	4.17%	3.97	0.73	18.43%	14.25%
NVS Novartis AG	$143.95	19.48%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$669.96	43.24%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.16	-21.96%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$89.49	-1.92%	3.11%	22.28	2.31	10.35%	14.02%
GSK GlaxoSmithKline PLC	$49.88	28.76%	3.54%	15.39	4.35	28.24%	14.54%
BSX Boston Scientific Corp.	$44.91	-54.03%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$83.96	-30.35%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$222.19	-18.53%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$519.08	-19.94%	0.00%	35.48	25.07	70.67%	25.03%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ACCD Historical Dividends

current DY: %

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Accolade

Accolade Inc.

Average Investor10 user rating

4.0 (1 people)

United States

19 years

Founded: 2007

2020

Time since IPO - 6 years

1.720

Employees

Accolade Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $313.00 million.

The company employs approximately 1.720 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Accolade Inc. reported $426.95 million in revenue, generating net income of $-294.04 million.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.

The company trades under the ticker ACCD.

Market cap

Net worth

$313.00 million

$313,000,000.00

Assets

$647.45 million

$647,450,000.00

Total Shares Outstanding

81.00 million

81,000,000

Average Daily Trading Volume

$1.36 million

$1,361,980.66

Sector

Health

Industry

Health Services and Providers

ACCD

ACCD revenue and profits

Financial Results ACCD

DRAG THE FRAME TO SEE MORE DATA

ACCD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$84.80 14,53% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$265.11 --6,98% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$61.77 78,27% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$377.85 46,64% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$41.25 --7,59% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,194.60 62,05% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$432.15 4,41% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$143.95 19,31% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35

CVS - CVS Health

$84.80 14,53% (12 M)

P/L

-0.79

3.01%

ROE

-178.93%

P/VP

1.42

CI - Cigna

$265.11 --6,98% (12 M)

P/L

10.57

1.69%

ROE

16.04%

P/VP

1.70

CNC - Centene

$61.77 78,27% (12 M)

P/L

-6.38

0.00%

ROE

-22.56%

P/VP

1.44

HUM - Humana

$377.85 46,64% (12 M)

P/L

35.53

0.93%

ROE

6.72%

P/VP

2.39

SNY - Sanofi

$41.25 --7,59% (12 M)

P/L

3.97

4.17%

ROE

18.43%

P/VP

0.73

LLY - Eli Lilly

$1,194.60 62,05% (12 M)

P/L

38.16

0.59%

ROE

78.84%

P/VP

30.09

HCA - HCA Healthcare

$432.15 4,41% (12 M)

P/L

12.06

0.70%

ROE

-244.72%

P/VP

-29.52

NVS - Novartis

$143.95 19,31% (12 M)

P/L

20.89

2.22%

ROE

30.39%

P/VP

6.35

Frequently Asked Questions

What is the price of Accolade (ACCD) today?

The current price of Accolade (ACCD) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Accolade (ACCD) pay dividends?

Accolade (ACCD) did not pay dividends over the past year.

Is Accolade (ACCD) a good investment?

Accolade (ACCD) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a -308% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of -%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Accolade (ACCD) stock?

You can buy Accolade (ACCD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ACCD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Accolade (ACCD) yield today?

Over the past month, Accolade (ACCD) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of -%.

If you were to purchase 100 shares of Accolade (ACCD) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ACCD

Accolade Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ACCD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ACCD WITH OTHER STOCK

current DY: %

5-year average DY: 0.00%

ABOUT Accolade

Accolade Inc.

United States

19 years

2020

1.720

PROFIT X PRICE ACCD

Financial Results ACCD

ACCD cash flow

Asset, Revenue and Profit Growth - ACCD

ACCD balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions